Table 2. Mean Values (SD) of the Systolic and Diastolic Blood Pressure (in mmHg) and Amylase Level (in U/ml) Pre- and Post-Pill Intake during Fear Acquisition for the Yohimbine HCl and Placebo Pill Condition (ie, Experiment I).
Fear acquisition yohimbine HCl | Pre-pill intake | Post-pill intake | T-test: two-tailed |
---|---|---|---|
Yohimbine condition | |||
Systolic BP | 126.1 (SD=10.1) | 138.0 (SD=11.9) | t14=−4.84, p<0.001 |
Diastolic BP | 72.5 (SD=6.3) | 77.7 (SD=8.3) | t14=−2.72, p<0.05 |
sAA Level | 91.4 (SD=127.1) | 168.9 (SD=233.9) | t11=−2.36, p<0.05 |
Placebo pill condition | |||
Systolic BP | 125.3 (SD=14.7) | 120.8 (SD=8.9) | t14=2.22, p<0.05 |
Diastolic BP | 73.0 (SD=7.5) | 70.3 (SD=7.0) | t14=2.25, p<0.05 |
sAA Level | 103.1 (SD=105.2) | 75.7 (SD=62.9) | t12<1 |